Diabetic Men Are At Higher Risk Of Death From Covid-19: Stud
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Previous studies have identified that people with diabetes have about two- to threefold increased risk of mortality due to Covid-19 compared to those without it. However, recent studies have found differences in associations of specific phenotypes of diabetes with comorbidities and complications.

But now, a larger study has found that men and older adults with a more advanced diabetes have a higher risk of death when infected with the novel coronavirus. The findings, showed that men with diabetes were 28 percent more likely to die with Covid-19 than women, while people aged over 65 with diabetes were over three times more likely to die than those under that age with diabetes.

With each five-year increase in age, the relative risk for Covid-19 related death in people living with diabetes increased by 43 percent, said the team of researchers. For the research, the team conducted a systematic review and meta-analysis of 22 studies and 17,687 people across countries in Asia, North America and Europe.

The research also found that patients using insulin to control their diabetes were found to be 75 percent more likely to die with Covid-19, while those treating their diabetes with metformin were 50 percent less likely to succumb to Covid-19. There were no clear associations between smoking, being overweight and being obese with risk of Covid-19-related death or the severity of the disease.

“Male sex, older age and some pre-existing conditions, as well as the use of insulin, most of which are potential indicators for a more progressive course of diabetes, were associated with increased risk of Covid-19 related death and severity in individuals with diabetes and SARS-CoV-2 infection, whereas metformin use was associated with a lower risk of death,” lead author said in a statement.